Pages that link to "Q34351124"
Jump to navigation
Jump to search
The following pages link to Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma (Q34351124):
Displaying 50 items.
- Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenase (Q24614496) (← links)
- Physiological and pathological implications of 5-hydroxymethylcytosine in diseases (Q26749375) (← links)
- IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma (Q26995506) (← links)
- Regulation of the Epigenome by Vitamin C (Q27000867) (← links)
- Developing epigenetic diagnostics and therapeutics for brain disorders (Q27022987) (← links)
- Epigenetics and the developmental origins of inflammatory bowel diseases (Q27687013) (← links)
- 2-Hydoxyglutarate: D/Riving Pathology in gLiomaS (Q28087807) (← links)
- Prostate cancer epigenetics and its clinical implications (Q28829460) (← links)
- Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis (Q30240261) (← links)
- 5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients (Q30275355) (← links)
- Hydroxymethylation as a Novel Environmental Biosensor (Q33644685) (← links)
- High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma (Q33845409) (← links)
- Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches (Q34305848) (← links)
- Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma (Q34500349) (← links)
- Chromatin Memory in the Development of Human Cancers (Q34979975) (← links)
- 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies (Q35033583) (← links)
- Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer. (Q35749302) (← links)
- Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies (Q35897966) (← links)
- IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis. (Q36008323) (← links)
- Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis. (Q36548751) (← links)
- 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas. (Q36569563) (← links)
- Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesis (Q36573115) (← links)
- AF9 promotes hESC neural differentiation through recruiting TET2 to neurodevelopmental gene loci for methylcytosine hydroxylation. (Q36882821) (← links)
- Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease (Q36956287) (← links)
- Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes (Q36969070) (← links)
- Tight correlation of 5-hydroxymethylcytosine and Polycomb marks in health and disease (Q37075892) (← links)
- Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers (Q37114055) (← links)
- Alterations of 5-hydroxymethylcytosine in human cancers (Q37226486) (← links)
- Technical advances in global DNA methylation analysis in human cancers. (Q37673323) (← links)
- Regulatory landscape and clinical implication of MBD3 in human malignant glioma. (Q37684657) (← links)
- 5-hydroxymethylcytosine: a new insight into epigenetics in cancer (Q38164206) (← links)
- 5-hydroxymethylcytosine profiling as an indicator of cellular state (Q38166838) (← links)
- Recent advances in the bioanalysis of modified nucleotides in epigenetic studies. (Q38167832) (← links)
- TET family proteins: new players in gliomas (Q38176267) (← links)
- The role of 5-hydroxymethylcytosine in human cancer (Q38210931) (← links)
- The role of inflammation in brain cancer (Q38211074) (← links)
- Oncometabolites-driven tumorigenesis: From genetics to targeted therapy (Q38240032) (← links)
- Circulating biomarker panels for targeted therapy in brain tumors (Q38252948) (← links)
- 5-hydroxymethylcytosine: a potential therapeutic target in cancer (Q38272312) (← links)
- The application of genome-wide 5-hydroxymethylcytosine studies in cancer research (Q38383659) (← links)
- The epigenetics of aging and neurodegeneration. (Q38527233) (← links)
- Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes (Q38551974) (← links)
- DNA methylation profiles in cancer diagnosis and therapeutics. (Q38650593) (← links)
- Differential expression of ten-eleven translocation genes in endometrial cancers (Q38871612) (← links)
- DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2. (Q38946696) (← links)
- Challenges for epigenetic research in inflammatory bowel diseases (Q39200926) (← links)
- 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma (Q40018006) (← links)
- Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma (Q41109977) (← links)
- Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype. (Q41503078) (← links)
- Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity (Q41887118) (← links)